0 items USD 0.00Search
- Did you mean
- here+
Your search for "HER2+" gave back 162 results.
HER2, also known as human epidermal growth factor receptor 2, is an important prognostic factor for breast cancer.HER2 is also expressed on the...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
HR+/HER2-Breast Cancer Market Analysis and Insights: Global HR+HER2- Breast Cancer Market The global HR+HER2- Breast Cancer market is projected to...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The demand of HER2 Antibodies is increasing, and primarily gaining from growing awareness regarding the prevalence of HER2 positive breast cancer...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
The global HER2 Testing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from...
Catalog:
LPI
June 2023
Price: USD 3,660.00
Market Analysis and Insights: Global HER-2 Targeted Drugs for Breast Cancer Market The global HER-2 Targeted Drugs for Breast Cancer market is...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Market Analysis and Insights: Global Targeted Drug HER2 Inhibitors for NSCLC Market The global Targeted Drug HER2 Inhibitors for NSCLC market is...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
HER2 (human epidermal growth factor receptor 2) is a protein that appears on the surface of some breast cancer cells. It may also be called HER2/neu...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
The global HER2 Testing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of %...
Catalog:
GIR
July 2023
Price: USD 3,480.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the HER2 Targeted Therapy market will undergo major changes...
Catalog:
Arsta
December 2022
Price: USD 3,260.00
The global HER2 Testing market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029...
Catalog:
GIR
July 2023
Price: USD 4,480.00
HER2 is the target of the monoclonal antibody trastuzumab (marketed as Herceptin). Trastuzumab is effective only in cancers where HER2 is over-...
Catalog:
LPI
February 2023
Price: USD 3,660.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the HER2 Targeted Therapy market will undergo major changes...
Catalog:
Arsta
August 2022
Price: USD 3,360.00
The “HER2 Targeted Therapy Industry Forecast” looks at past sales and reviews total world HER2 Targeted Therapy sales in 2022, providing a...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The demand of HER2 Antibodies is increasing, and primarily gaining from growing awareness regarding the prevalence of HER2 positive breast cancer...
Catalog:
LPI
February 2023
Price: USD 3,660.00
HER2, also known as human epidermal growth factor receptor 2, is an important prognostic factor for breast cancer.HER2 is also expressed on the...
Catalog:
LPI
February 2023
Price: USD 3,660.00
